The ReProgram
Ozempic Isn’t a Weight-Loss Drug | The Real Science of GLP-1s
16:26
The ReProgram Episode 7
In this episode of the Reprogram Podcast, Dr. George Murphy explores the rise of GLP-1 drugs like Ozempic, Wegovy, and Mounjaro, discussing their mechanisms, effects on metabolism, and implications for aging and healthspan. He emphasizes that these drugs are not merely weight loss solutions but agents that act on multiple organs to reprogram how the body regulates energy…